Leukemia research has revolutionized treatment with CAR-T cell therapy, targeted therapies, and improved stem cell transplantation techniques.
A registry-based analysis of 11,681 US interventional cancer trials registered on ClinicalTrials.gov between 2008 and 2024 found that industry sponsors now outnumber federal sponsors nearly 5 to 1 (4.53-to-1 overall), with the ratio widening from 2.72-to-1 in 2008–2012 to 6.44-to-1 in 2019–2024.
Phase 3 randomized trial of 909 patients with previously untreated CLL across 174 sites in 13 countries